Navigation Links
BiPAP® Plus Bi-level System

ProductsBiPAP® Plus Bi-level System
Company Respironics, Inc.
Item BiPAP® Plus Bi-level System
Features 
  • Compact, Lightweight And Easily Portable to fit well on patients nightstands and with their lifestyles
  • Quiet so the patient and bed partner are not disturbed by noise
  • Ramp Lowers The Pressures at the start of therapy
  • Encore SmartCard records the date, time, ramp usage, duration of each use, and FOSQ answers
  • Advanced Blower Design And Pressure Feedback provide stable pressure and allow the system to tolerate most mask leaks
  • Compensates For Altitude Changes to provide comfortable, accurate pressure despite changes in altitude
  • Automatic On/Off Feature eliminates the need for a remote control yet still provides easy control over therapy
  • Mask Removal Indicator can be set to sound in case the mask is removed (may not function with all masks and circuit configurations or at high altitudes)
  • Dual Time Meters provide immediate status of total machine usage and cumulative patient compliance (time at pressure)
  • Universal Power Supply simplifies travel worldwide
Description The BiPAP Pro with Bi-Flex bi-level system, while in BiPAP mode, establishes the time that the BiPAP Pro takes to change from EPAP to IPAP. It also includes Digital Auto-Trak Sensitivity™ which automatically triggers the device to cycle between inspiratory and expiratory pressures based on the patients breathing rhythm. Auto-Trak also compensates for any leaks that may occur. The Encore® SmartCard® stores information on system use, therapy and quality of life. The SmartCard can be programmed with the patients prescription settings so they are automatically transferred to the device when the card is inserted. Also includes Functional Outcomes of Sleep Questionnaire (FOSQ) so patients can periodically complete the questionnaire, and the data recorded on the SmartCard can be used to assess compliance.
Info Respironics, Inc.
Customer Service: (800) 345-6443
Web site: http://www.respironics.com

Related medicine products :

1. BiPAP® Pro 2 with Bi-Flex®
2. BiPAP® Pro Bi-level System with Bi-Flex®
3. Silicone Oil Cannula System - 20 Gauge
4. Silicone Oil Cannula System - 19 Gauge
5. SuperVu Galilean System
6. KOWA nonmyd 7 / VK-2 Digital Imaging System
7. KOWA nonmyd a-D / VK-2 Digital Imaging System
8. Refraction System RT-2100
9. Odyssey Phacoemulsification System
10. SIStem Phacoemulsification System
11. Precisionist Phacoemulsification System
Breaking Medicine Technology:Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 2Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 3RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3Beckman Coulter Announces Third Quarter 2009 Results 5858 1Beckman Coulter Announces Third Quarter 2009 Results 5858 2Beckman Coulter Announces Third Quarter 2009 Results 5858 3Beckman Coulter Announces Third Quarter 2009 Results 5858 4Beckman Coulter Announces Third Quarter 2009 Results 5858 5Beckman Coulter Announces Third Quarter 2009 Results 5858 6Beckman Coulter Announces Third Quarter 2009 Results 5858 7Beckman Coulter Announces Third Quarter 2009 Results 5858 8Beckman Coulter Announces Third Quarter 2009 Results 5858 9Beckman Coulter Announces Third Quarter 2009 Results 5858 10Beckman Coulter Announces Third Quarter 2009 Results 5858 11Beckman Coulter Announces Third Quarter 2009 Results 5858 12Beckman Coulter Announces Third Quarter 2009 Results 5858 13Beckman Coulter Announces Third Quarter 2009 Results 5858 14Beckman Coulter Announces Third Quarter 2009 Results 5858 15Beckman Coulter Announces Third Quarter 2009 Results 5858 16Beckman Coulter Announces Third Quarter 2009 Results 5858 17Beckman Coulter Announces Third Quarter 2009 Results 5858 18Beckman Coulter Announces Third Quarter 2009 Results 5858 19Beckman Coulter Announces Third Quarter 2009 Results 5858 20Beckman Coulter Announces Third Quarter 2009 Results 5858 21Beckman Coulter Announces Third Quarter 2009 Results 5858 22Beckman Coulter Announces Third Quarter 2009 Results 5858 23Beckman Coulter Announces Third Quarter 2009 Results 5858 24Beckman Coulter Announces Third Quarter 2009 Results 5858 25Beckman Coulter Announces Third Quarter 2009 Results 5858 26Beckman Coulter Announces Third Quarter 2009 Results 5858 27Beckman Coulter Announces Third Quarter 2009 Results 5858 28Beckman Coulter Announces Third Quarter 2009 Results 5858 29Beckman Coulter Announces Third Quarter 2009 Results 5858 30Beckman Coulter Announces Third Quarter 2009 Results 5858 31Beckman Coulter Announces Third Quarter 2009 Results 5858 32Beckman Coulter Announces Third Quarter 2009 Results 5858 33Beckman Coulter Announces Third Quarter 2009 Results 5858 34Beckman Coulter Announces Third Quarter 2009 Results 5858 35Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 1Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 2Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 4Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 5Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 6Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 7Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 8BioCryst to Present at Oppenheimer Healthcare Conference 5852 1BioCryst to Present at Oppenheimer Healthcare Conference 5852 2